TIDMDXSP

DXS INTERNATIONAL PLC

Result of AGM

The Board of DXS International plc (the "Company"), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems is pleased to announce that at the Annual General Meeting held on 30 November, all resolutions were duly passed.

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

 
David Immelman (Chief Executive)            01252 719800 
 DXS International plc             david@dxs-systems.com 
Wrecclesham House 
 Wrecclesham Road 
 Farnham 
 Surrey 
 GU10 4PS 
www.dxs-systems.co.uk 
 
 
Corporate Advisor 
City & Merchant 
 David Papworth     0207 101 7676 
 
 
Corporate Broker 
Hybridan LLP 
 Claire Louise Noyce   020 3764 2341

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

(END) Dow Jones Newswires

December 04, 2023 11:00 ET (16:00 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni DXS (AQSE:DXSP)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di DXS
Grafico Azioni DXS (AQSE:DXSP)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di DXS